What medications are commonly used in conjunction with loratinib?
Because targeted therapies carry the risk of interactions, patients should not self-medicate. Whether or not other medications need to be combined for treatment must be strictly followed according to the medication regimen prescribed by the doctor based on the individual patient's condition. During treatment, the doctor will adjust the medication combination based on treatment effectiveness and side effects.
Instructions before use
Loratinib is a targeted therapy specifically used to treat ALK-positive locally advanced or metastatic non-small cell lung cancer. This drug must be used under the guidance of a physician experienced in oncology treatment, with particular attention to the following: It is absolutely contraindicated in individuals taking potent CYP3A inducers (such as rifampin); it is generally not recommended for patients with moderate to severe liver dysfunction, severe kidney dysfunction, or those planning pregnancy, pregnant women, and breastfeeding women. If medication is deemed necessary after a physician's evaluation, close monitoring is required. Special care should be taken to avoid concurrent use with other medications. If you are currently taking other medications or have underlying medical conditions, you must inform your doctor in advance.
Who is strictly prohibited from using loratinib?
Loratinib is contraindicated in patients currently using potent CYP3A inducers (such as rifampin). This is because the combined use of these two drugs can cause severe liver toxicity, potentially leading to a rapid deterioration of the patient's condition.
